What medications are used to treat premenstrual syndrome (PMS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Premenstrual Syndrome (PMS)

Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for premenstrual syndrome due to their proven efficacy in reducing both physical and psychological symptoms. 1

First-Line Treatments

SSRIs

  • FDA-approved SSRIs for PMS/PMDD:

    • Fluoxetine (Prozac) 2, 1
    • Paroxetine (controlled-release) 1
    • Sertraline 1
    • Citalopram 1
    • Escitalopram 1
  • Dosing options:

    • Continuous daily dosing (more effective than luteal phase dosing) 1
    • Luteal phase dosing (starting 14 days before expected menses) 1
  • Efficacy:

    • Moderate effect size for reducing overall PMS symptoms (SMD -0.57) 1
    • Continuous administration is more effective than luteal phase dosing (SMD -0.69 vs -0.39) 1
  • Common side effects:

    • Nausea (most common)
    • Insomnia
    • Sexual dysfunction
    • Fatigue
    • Dizziness
    • Sweating
    • Dry mouth 1

Second-Line Treatments

Other Psychiatric Medications

  • SNRIs:

    • Venlafaxine 3
    • Duloxetine 3
  • Anxiolytics:

    • Alprazolam (for anxiety symptoms) 3, 4
    • Buspirone 3

Hormonal Treatments

  • Combined hormonal contraceptives:
    • Primarily improve physical symptoms 5
    • Contraindicated in women with migraine with aura 6

Additional Treatment Options

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

  • Naproxen (can be used during perimenstrual period for pain and inflammation) 6, 4

Supplements

  • Calcium supplementation:
    • Only supplement with consistent evidence of benefit 3

For Specific Symptoms

For Menstrual Migraines

  • Long-acting NSAIDs (naproxen) starting 2 days before expected menstruation 6
  • Triptans (frovatriptan or naratriptan) for 5 days starting 2 days before expected menstruation 6

For Problems with Ejaculation (if relevant)

  • Daily SSRIs (paroxetine, sertraline, citalopram, fluoxetine) 6
  • Clomipramine dosed on demand 6
    • Caution: Never combine clomipramine with MAOIs (including moclobemide) due to risk of serotonin syndrome 7

Treatment Algorithm

  1. Start with lifestyle modifications:

    • Regular exercise
    • Stress reduction techniques
    • Dietary changes (reducing caffeine, salt, alcohol)
  2. If symptoms persist, initiate pharmacotherapy:

    • For mild-moderate symptoms: Start with an SSRI (fluoxetine, sertraline, or citalopram)
    • Begin with continuous dosing for maximum efficacy
    • If side effects are problematic, consider switching to luteal phase dosing
  3. If inadequate response to first SSRI:

    • Try a different SSRI
    • Consider an SNRI (venlafaxine or duloxetine)
  4. For specific symptom management:

    • For physical pain: Add NSAIDs during symptomatic period
    • For anxiety: Consider adding an anxiolytic
    • For menstrual migraines: Add specific migraine prophylaxis
  5. For severe, treatment-resistant cases:

    • Consider hormonal treatments
    • Evaluate for comorbid conditions

Important Considerations

  • Monitor for side effects, particularly in the first weeks of treatment
  • Assess response after 2-3 months of treatment 6
  • Use headache/symptom calendars to track response 6
  • Consider CYP2D6/CYP2C19 genetic testing in cases of treatment failure or unusual side effects 6
  • Avoid combining serotonergic medications due to risk of serotonin syndrome 7

The evidence strongly supports that SSRIs are the most effective medication class for PMS, with continuous dosing providing better symptom control than luteal phase dosing.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Serotonin Syndrome Risk with Clomipramine and Moclobemide Combination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.